UPDATE | November 18, 2022

Overcoming Bottlenecks in mRNA Manufacturing

  • MAIL

WHITEPAPER - Overcoming Bottlenecks in mRNA Manufacturing 

Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market. 

WHITEPAPER - Overcoming Bottlenecks in mRNA Manufacturing 

Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market. 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required